The Center for Science in the Public Interest (CSPI) has grave concerns about this draft guidance, which has the potential to further lower the already-too-low standards for approval of medical devices. We urge the FDA to withdraw the draft guidance or, at a minimum, to restrict it to breakthrough devices.

View resource